Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Advances in Physiology Education|March 28, 2024
PharmaMemory: an interactive, animated web application for learning autonomic physiology and pharmacologyTimothy Rosencrans, Ryan Jones, Daniel Griffin, et al.
Atencion Primaria|February 5, 2010
[Factors involved in the development of the community projects. Observational study of the Catalonian primary care centers AUPA network]Estíbaliz López Torrent, Carme Forcada Vega, Frederick Miller, et al.
Clinical Nephrology|November 21, 2012
Reversible left ventricular dysfunction and acute kidney injury in a patient with nonamyloid light chain deposition diseaseNand K Wadhwa, Amit Kamra, Hal A Skopicki, et al.
Case Reports in Rheumatology|October 26, 2012
Intestinal infarction and portal vein thrombosis in a patient with henoch schonlein purpuraMekdess Abebe, Asha Patnaik, Frederick Miller, et al.
Arthritis and Rheumatism|November 6, 2004
Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis developsTerrance O'Hanlon, Bhanu Koneru, Elham Bayat, et al.
JMIR Medical Informatics|July 20, 2021
A Biomedical Knowledge Graph System to Propose Mechanistic Hypotheses for Real-World Environmental Health Observations: Cohort Study and Informatics ApplicationKaramarie Fecho, Chris Bizon, Frederick Miller, et al.
International Journal of Cancer|December 30, 2009
Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodentsShinya Shibutani, Radha R Bonala, Thomas Rosenquist, et al.
Kidney & Blood Pressure Research|March 1, 2013
Variation in presentation and presence of DNA adducts and p53 mutations in patients with endemic nephropathy--an environmental form of the aristolochic acid nephropathySandra Karanović, Ivana Vuković Lela, Bojan Jelaković, et al.
Kidney International|November 11, 2011
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acidBojan Jelaković, Sandra Karanović, Ivana Vuković-Lela, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 17, 2010
Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]Marianna Penzo, Raffaella Molteni, Tomomi Suda, et al.
Pageof 3